# Kartoon Studios, Inc.: financial statements, quarterly

TOON · NYSE · CIK 1355848 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/toon.md) · [Financials](/companies/toon/financials.md) · [Filings](/companies/toon/filings.md) · [Insiders](/companies/toon/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/toon/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.1](/filings/0001683168-24-008023.md) | [8.8 d](/filings/0001683168-25-002049.md) | [6.1](/filings/0001683168-25-003620.md) | [8.4](/filings/0001683168-25-006078.md) | [8.7](/filings/0001683168-25-008374.md) | [9.4 d](/filings/0001683168-26-002452.md) | [9.5](/filings/0001683168-26-003977.md) | [10.3](/filings/0001683168-26-006405.md) | [9.9](/filings/0001683168-25-008374.md) | [9.7 d](/filings/0001683168-26-002452.md) | [7.2](/filings/0001683168-26-003977.md) | [5.8](/filings/0001683168-26-006405.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(12.6)](/filings/0001683168-24-008023.md) | [(29.2) d](/filings/0001683168-25-002049.md) | [(6.3)](/filings/0001683168-25-003620.md) | [(4.7)](/filings/0001683168-25-006078.md) | [(2.5)](/filings/0001683168-25-008374.md) | [(3.5) d](/filings/0001683168-26-002452.md) | [(3.1)](/filings/0001683168-26-003977.md) | [(3.2)](/filings/0001683168-26-006405.md) | [(2.9)](/filings/0001683168-25-008374.md) | [(3.7) d](/filings/0001683168-26-002452.md) | [(2.8)](/filings/0001683168-26-003977.md) | [(3.4)](/filings/0001683168-26-006405.md) |
| Interest expense | $m | [0.7](/filings/0001355848-23-000031.md) | [0.3 d](/filings/0001683168-25-002049.md) | [0.2](/filings/0001683168-25-003620.md) | [0.2](/filings/0001683168-25-006078.md) | [0.2](/filings/0001683168-25-008374.md) | [0.2 d](/filings/0001683168-26-002452.md) | [0.1](/filings/0001683168-26-003977.md) | [0.2](/filings/0001683168-26-006405.md) | [0.2](/filings/0001683168-25-008374.md) | [0.2 d](/filings/0001683168-26-002452.md) | [0.2](/filings/0001683168-26-003977.md) | [0.2](/filings/0001683168-26-006405.md) |
| Income tax | $m | [0.0](/filings/0001683168-24-008023.md) | [(0.0) d](/filings/0001683168-25-002049.md) | [0.0](/filings/0001683168-25-003620.md) | [0.0](/filings/0001683168-25-006078.md) | [0.0](/filings/0001683168-25-008374.md) | [(0.6) d](/filings/0001683168-26-002452.md) | [0.0](/filings/0001683168-25-003620.md) | [0.0](/filings/0001683168-26-006405.md) | [0.0](/filings/0001683168-25-008374.md) | [(0.1) d](/filings/0001683168-26-002452.md) | [0.0](/filings/0001683168-26-003977.md) | [0.6](/filings/0001683168-26-006405.md) |
| Net income | $m | [(15.5)](/filings/0001683168-24-008023.md) | [(25.4) d](/filings/0001683168-25-002049.md) | [(7.0)](/filings/0001683168-25-003620.md) | [(5.9)](/filings/0001683168-25-006078.md) | [(2.1)](/filings/0001683168-25-008374.md) | [(5.8) d](/filings/0001683168-26-002452.md) | [(6.5)](/filings/0001683168-26-003977.md) | [(6.2)](/filings/0001683168-26-006405.md) | [(6.6)](/filings/0001683168-25-008374.md) | [(5.3) d](/filings/0001683168-26-002452.md) | [(6.4)](/filings/0001683168-26-003977.md) | [27.0](/filings/0001683168-26-006405.md) |
| Diluted EPS | $ per share | [(0.44)](/filings/0001683168-24-008023.md) | not reported | [(0.20)](/filings/0001683168-25-003620.md) | [(0.15)](/filings/0001683168-25-006078.md) | [(0.05)](/filings/0001683168-25-008374.md) | not reported | [(0.14)](/filings/0001683168-26-003977.md) | [(0.13)](/filings/0001683168-26-006405.md) | [(0.14)](/filings/0001683168-25-008374.md) | not reported | [(0.10)](/filings/0001683168-26-003977.md) | [0.38](/filings/0001683168-26-006405.md) |
| Basic EPS | $ per share | [(0.44)](/filings/0001683168-24-008023.md) | not reported | [(0.20)](/filings/0001683168-25-003620.md) | [(0.15)](/filings/0001683168-25-006078.md) | [(0.05)](/filings/0001683168-25-008374.md) | not reported | [(0.14)](/filings/0001683168-26-003977.md) | [(0.13)](/filings/0001683168-26-006405.md) | [(0.14)](/filings/0001683168-25-008374.md) | not reported | [(0.10)](/filings/0001683168-26-003977.md) | [0.41](/filings/0001683168-26-006405.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-11) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.6](/filings/0001683168-25-002049.md) | [2.8](/filings/0001355848-24-000071.md) | [2.7](/filings/0001355848-24-000113.md) | [4.6](/filings/0001683168-24-008023.md) | [7.9](/filings/0001683168-26-002452.md) | [2.3](/filings/0001683168-25-003620.md) | [2.1](/filings/0001683168-25-006078.md) | [0.9](/filings/0001683168-25-008374.md) | [2.9](/filings/0001683168-26-003977.md) | [5.0](/filings/0001683168-26-003977.md) | [39.2](/filings/0001683168-26-006405.md) | [7.7](/filings/0001683168-26-006405.md) |
| Current assets | $m | [55.7](/filings/0001683168-25-002049.md) | [41.0](/filings/0001355848-24-000071.md) | [38.8](/filings/0001355848-24-000113.md) | [37.2](/filings/0001683168-24-008023.md) | [34.7](/filings/0001683168-26-002452.md) | [25.1](/filings/0001683168-25-003620.md) | [25.5](/filings/0001683168-25-006078.md) | [27.1](/filings/0001683168-25-008374.md) | [35.8](/filings/0001683168-26-006405.md) | [30.7](/filings/0001683168-26-003977.md) | not reported | [63.0](/filings/0001683168-26-006405.md) |
| Total assets | $m | [111](/filings/0001683168-25-002049.md) | [93.3](/filings/0001355848-24-000071.md) | [89.0](/filings/0001355848-24-000113.md) | [87.3](/filings/0001683168-24-008023.md) | [85.5](/filings/0001683168-26-002452.md) | [71.7](/filings/0001683168-25-003620.md) | [70.0](/filings/0001683168-25-006078.md) | [66.7](/filings/0001683168-25-008374.md) | [70.9](/filings/0001683168-26-006405.md) | [63.6](/filings/0001683168-26-003977.md) | not reported | [94.5](/filings/0001683168-26-006405.md) |
| Current liabilities | $m | [45.6](/filings/0001683168-25-002049.md) | [34.9](/filings/0001355848-24-000071.md) | [33.6](/filings/0001355848-24-000113.md) | [33.7](/filings/0001683168-24-008023.md) | [33.4](/filings/0001683168-26-002452.md) | [26.8](/filings/0001683168-25-003620.md) | [30.4](/filings/0001683168-25-006078.md) | [32.5](/filings/0001683168-25-008374.md) | [33.5](/filings/0001683168-26-006405.md) | [31.4](/filings/0001683168-26-003977.md) | not reported | [31.6](/filings/0001683168-26-006405.md) |
| Total liabilities | $m | [58.2](/filings/0001683168-25-002049.md) | [46.9](/filings/0001355848-24-000071.md) | [44.6](/filings/0001355848-24-000113.md) | [44.5](/filings/0001683168-24-008023.md) | [49.0](/filings/0001683168-26-002452.md) | [41.6](/filings/0001683168-25-003620.md) | [40.3](/filings/0001683168-25-006078.md) | [42.7](/filings/0001683168-25-008374.md) | [43.4](/filings/0001683168-26-006405.md) | [41.0](/filings/0001683168-26-003977.md) | not reported | [40.9](/filings/0001683168-26-006405.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [51.6](/filings/0001683168-25-002049.md) | [44.8](/filings/0001355848-24-000071.md) | [42.7](/filings/0001355848-24-000113.md) | [41.2](/filings/0001683168-24-008023.md) | [35.0](/filings/0001683168-26-002452.md) | [28.6](/filings/0001683168-25-003620.md) | [28.4](/filings/0001683168-25-006078.md) | [22.6](/filings/0001683168-25-008374.md) | [26.2](/filings/0001683168-26-006405.md) | [21.3](/filings/0001683168-26-003977.md) | not reported | [52.4](/filings/0001683168-26-006405.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.6) d](/filings/0001683168-24-008023.md) | [4.1 d](/filings/0001683168-25-002049.md) | [3.8](/filings/0001683168-25-003620.md) | [(6.5) d](/filings/0001683168-25-006078.md) | [1.5 d](/filings/0001683168-25-008374.md) | [(2.4) d](/filings/0001683168-26-002452.md) | [(1.8)](/filings/0001683168-26-003977.md) | [(4.5) d](/filings/0001683168-26-006405.md) | [(5.5) d](/filings/0001683168-25-008374.md) | [0.4 d](/filings/0001683168-26-002452.md) | [(2.9)](/filings/0001683168-26-003977.md) | [34.3 d](/filings/0001683168-26-006405.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001683168-24-008023.md) | [0.0 d](/filings/0001683168-25-002049.md) | [0.0](/filings/0001683168-25-003620.md) | [0.0 d](/filings/0001683168-25-006078.md) | [0.0 d](/filings/0001683168-25-008374.md) | [0.0 d](/filings/0001683168-26-002452.md) | [0.0](/filings/0001683168-26-003977.md) | [0.1 d](/filings/0001683168-26-006405.md) | [0.0 d](/filings/0001683168-25-008374.md) | [0.0 d](/filings/0001683168-26-002452.md) | [0.0](/filings/0001683168-26-003977.md) | [0.0 d](/filings/0001683168-26-006405.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.7](/filings/0001355848-23-000031.md) | [32.0](/filings/0001355848-24-000071.md) | [32.4](/filings/0001355848-24-000113.md) | [35.1](/filings/0001683168-24-008023.md) | [35.3](/filings/0001683168-25-003620.md) | [38.4](/filings/0001683168-25-006078.md) | [39.5](/filings/0001683168-25-008374.md) | [46.7](/filings/0001683168-26-003977.md) | [47.8](/filings/0001683168-26-006405.md) | [48.1](/filings/0001683168-25-008374.md) | [62.7](/filings/0001683168-26-003977.md) | [71.0](/filings/0001683168-26-006405.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,204,105 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001683168-26-006405.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.